Latest antibodies Stories
Novel methodology leverages somatic hypermutation to rapidly generate humanized therapeutic antibodies with >97% human content SAN DIEGO, April 3, 2014 /PRNewswire/ -- AnaptysBio,
SAN FRANCISCO and WALTHAM, Mass., March 31, 2014 /PRNewswire/ -- Kindred Biosciences, Inc.
MONROVIA, Calif., March 28, 2014 /PRNewswire/ -- Xencor, Inc.
Cannabinoid Receptor 1 is most recent GPCR to be targeted by RuiYi's iCAPS platform LA JOLLA, Calif. and SHANGHAI, March 27, 2014 /PRNewswire/ -- RuiYi, Inc.
MONROVIA, Calif., March 24, 2014 /PRNewswire/ -- Xencor, Inc.
Telephus Advances TPH 101 Program Towards Candidate Selection SAN DIEGO, March 18, 2014 /PRNewswire/ -- BioAtla, a global biotechnology company focused on the development of differentiated
CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust
DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/43nvqj/cancer_monoclonal) has announced the addition of the "Cancer
- One who brings meat to the table; hence, in some countries, the official title of the grand master or steward of the king's or a nobleman's household.
More Images (1 images) »